The Summit will begin with a plenary keynote session, and then break into four concurrent conferences, all of which will talk about complementary areas of the latest breakthroughs in the immunology field:

• 13th Cytokines & Inflammation: This meeting provides a forum for researchers to discuss the latest advances in targeting cytokines and chemokines for therapeutic interventions, cytokines and metabolism, and cytokines signaling pathways.
• 7th Immunotherapeutics & Immunomonitoring: Experts will cover recent advances in immunotherapy and how they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment.
• 3rd Immunogenicity and Immunotoxicity: Delegates will learn about ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins.
• 2nd Innate Immunity: Speakers will address discoveries in toll-like receptors, inflammasome reactions, the role of the microbiome and non-pathogenic bacteria, and many more.